AmCad BioMed (4188.TWO) Stock Price

AmCad BioMed Price

CLOSED
18.45
​
Market closed

Revenue has compounded at 43.2% per year over the past 13 years to 30.44 M TWD. AmCad BioMed's net margin stands at -183.1%, down from -29.8% several years earlier.

AmCad BioMed stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AmCad BioMed business model & stock analysis

AmCad BioMed Corp, headquartered in Taipei City, Taiwan, specializes in manufacturing and selling medical diagnostic software devices. The company offers products like AmCAT-UT Detection, a computer-aided detection system for thyroid ultrasound, and AmCAD-UT Diagnosis, a computer-aided diagnosis system for the same purpose. Listed on 26 December 2013, AmCad BioMed operates in Taiwan, China, and Hong Kong markets.

Frequently asked questions about AmCad BioMed

Converted at the current exchange rate, the AmCad BioMed share trades at 0.51 EUR (18.45 TWD).

The revenue cannot currently be calculated for AmCad BioMed.

The profit cannot currently be calculated for AmCad BioMed.

The P/E ratio cannot be calculated for AmCad BioMed at the moment.

The P/S cannot be calculated for AmCad BioMed currently.

The Eulerpool Quality Score for AmCad BioMed is 3/10.

The ISIN of AmCad BioMed is TW0004188008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of AmCad BioMed is 4188.TWO. The ticker symbol is used to trade AmCad BioMed shares on the stock exchange.

Fair ValueTerminal
18.45 TWD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website amcad.com.tw
Country
Taiwan
Currency
TWD
Initial public offering
Dec 26, 2013
ISIN
TW0004188008
Cusip
Y0102N109
Market capitalization
1.17 B TWDSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
2.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.69 %
Last updated Oct 28, 2026, 5:53 PM

AmCad BioMed Peer Group

AmCad BioMed FIGI

4188:TT (Taipei Stock Exchange) · BBG005Q5BB47